glucuronyl-glucosamine-glycan-sulfate and Heart-Failure

Chronic congestive heart failure is one of the risk groups of acquired hypercoagulant and hyperviscous state. In a group of patients with medium and severe cardiac failure the administration of sulodexide led to an increased activation of the fibrinolytic potential--a drop of PAI-1 and fibrinogen, to an increased activation of anticoagulatory potential--an increase of AT III and reduced plasma viscosity. Global coagulation and biochemical screening parameters were not affected by treatment. Administration of the preparation did not exert important undesirable effects and was well tolerated.

Topics: Aged; Antithrombin III; Blood Coagulation; Blood Viscosity; Female; Fibrinogen; Glycosaminoglycans; Heart Failure; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1